Nonviral siRNA delivery systems for pancreatic cancer therapy
Volume: 118, Issue: 10, Pages: 3669 - 3690
Published: Jul 8, 2021
Abstract
The serious drawbacks of the conventional treatment of pancreatic ductal adenocarcinoma (PDAC) such as nonspecific toxicity and high resistance to chemo and radiation therapy, have prompted the development and application of countless small interfering RNA (siRNA)-based therapeutics. Recent advances in drug delivery systems hold great promise for improving siRNA-based therapeutics and developing a new class of drugs, known as nano-siRNA drugs....
Paper Details
Title
Nonviral siRNA delivery systems for pancreatic cancer therapy
Published Date
Jul 8, 2021
Volume
118
Issue
10
Pages
3669 - 3690
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History